STOCK TITAN
  1. Home
  2. Sec-filings
  3. ONC
  4. [Form 4] BeOne Medicines Ltd. Insider Trading Activity

BeOne Medicines (ONC) president disposes ADS to cover RSU tax

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

BeOne Medicines Ltd. President and COO Wu Xiaobin reported a small share disposal tied to tax withholding rather than a discretionary sale. On June 23, 2026, 1,292 American Depositary Shares (ADS) were sold at a weighted average price of $276.2592 per ADS under a mandatory tax withholding provision associated with the vesting of a restricted share unit award.

The restricted share units vest in four equal installments on each anniversary of June 22, 2022, subject to continued service, with potential accelerated vesting upon certain termination events. Following this transaction, Wu holds 12,365 ADS directly, 4,000 ADS indirectly through his spouse, and 1,273,724 ordinary shares directly.

Positive

  • None.

Negative

  • None.
Insider Wu Xiaobin
Role President and COO
Sold 1,292 shs ($357K)
Type Security Shares Price Value
Sale American Depositary Shares 1,292 $276.2592 $357K
holding Ordinary Shares -- -- --
holding American Depositary Shares -- -- --
holding American Depositary Shares -- -- --
Holdings After Transaction: American Depositary Shares — 0 shares (Direct, null); Ordinary Shares — 1,273,724 shares (Direct, null); American Depositary Shares — 4,000 shares (Indirect, By Wife)
Footnotes (1)
  1. Each American Depositary Share represents 13 Ordinary Shares. The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.23 to $276.475, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
ADS sold for tax withholding 1,292 ADS Open-market tax-related sale on June 23, 2026
Weighted average sale price $276.2592 per ADS Tax-withholding sale on June 23, 2026
Direct ADS holdings after transaction 12,365 ADS Reported direct position following June 23, 2026 transactions
Indirect ADS holdings via spouse 4,000 ADS Indirect ownership "By Wife" as of June 23, 2026
Direct ordinary share holdings 1,273,724 ordinary shares Direct position as of June 23, 2026
ADS to ordinary share ratio 1 ADS = 13 ordinary shares Equity structure referenced in footnote
American Depositary Shares financial
"Each American Depositary Share represents 13 Ordinary Shares."
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
restricted share unit award financial
"in connection with the vesting of a restricted share unit award previously granted"
mandatory tax withholding financial
"pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement"
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
unvested securities financial
"Unvested securities are subject to accelerated vesting upon certain termination events."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wu Xiaobin
(Last)(First)(Middle)
C/O BEONE MEDICINES I GMBH
AESCHENGRABEN 27, 21ST FLOOR
(Street)
BASEL4051
(City)(State)(Zip)
SWITZERLAND
(Country)		2. Issuer Name and Ticker or Trading Symbol
BeOne Medicines Ltd. [ ONC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President and COO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares1,273,724D
American Depositary Shares(1)12,365D
American Depositary Shares(1)4,000IBy Wife
American Depositary Shares(1)06/23/2026S(2)1,292D$276.2592(3)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Each American Depositary Share represents 13 Ordinary Shares.
2. The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.23 to $276.475, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Remarks:
/s/ Qing Nian, as Attorney-in-Fact06/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did BeOne Medicines (ONC) report for Wu Xiaobin?

BeOne Medicines reported that President and COO Wu Xiaobin disposed of 1,292 American Depositary Shares. The sale was executed to satisfy mandatory tax withholding obligations arising from the vesting of a restricted share unit award, rather than a discretionary open-market sale decision.

How many BeOne Medicines (ONC) ADS did Wu Xiaobin sell and at what price?

Wu Xiaobin disposed of 1,292 American Depositary Shares at a weighted average price of $276.2592 per ADS. The shares were sold in multiple trades between $276.23 and $276.475, executed specifically to cover tax withholding related to restricted share unit vesting.

Was the BeOne Medicines (ONC) insider sale by Wu Xiaobin discretionary?

The reported sale was not discretionary; it fulfilled a mandatory tax withholding provision. The transaction stemmed from the vesting of a previously granted restricted share unit award, meaning the disposition reflects tax obligations rather than a voluntary change in Wu Xiaobin’s investment stance.

What BeOne Medicines (ONC) holdings does Wu Xiaobin retain after the reported transaction?

After the transaction, Wu Xiaobin holds 12,365 American Depositary Shares directly, 4,000 ADS indirectly through his spouse, and 1,273,724 ordinary shares directly. These remaining positions indicate he continues to maintain a substantial equity stake in BeOne Medicines following the tax-related sale.

How do BeOne Medicines (ONC) ADS relate to ordinary shares in this Form 4?

Each American Depositary Share of BeOne Medicines represents 13 ordinary shares, according to the filing footnotes. This ratio links U.S.-traded ADS to the underlying ordinary shares, helping investors interpret the scale of Wu Xiaobin’s ADS transactions and ongoing ordinary share holdings.

What are the vesting terms of Wu Xiaobin’s restricted share units at BeOne Medicines (ONC)?

The restricted share unit award vests in four equal installments, with one quarter vesting on each anniversary of June 22, 2022, subject to continued service. Unvested units may vest earlier upon certain termination events, which can accelerate recognition and related tax obligations for Wu Xiaobin.